Wai Chun Bio-Technology Limited (HKG:0660)

Wai Chun Bio-Technology Revenue

In the fiscal year ending June 30, 2025, Wai Chun Bio-Technology had annual revenue of 377.17M HKD with 1.92% growth. Wai Chun Bio-Technology had revenue of 216.11M in the half year ending June 30, 2025, a decrease of -41.37%.

• Revenue: 377.17M
• Revenue Growth: +1.92%
• P/S Ratio: 0.12
• Revenue / Employee: 6.29M
• Employees: 61
• Market Cap: 46.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	377.17M	7.10M	1.92%
Jun 30, 2024	370.07M	-403.59M	-52.17%
Jun 30, 2023	773.65M	102.20M	15.22%
Jun 30, 2022	671.46M	176.08M	35.54%
Dec 31, 2021	495.38M	-72.18M	-12.72%